Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

S[+] apomorphine

EU orphan designation number: EU/3/12/954   
Active ingredient: S[+] apomorphine
Indication: Treatment of amyotrophic lateral sclerosis
Sponsor: University of Sheffield
Western Bank, Sheffield S10 2TN, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/02/2012 Orphan designation EMA/OD/106/11 (2012)880 of 9/02/2012
4/04/2012 Change of name and/or address of sponsor EMA/OD/106/11